DISC-1 pathway activators in the control of neurogenesis
US10124035B2 · kind B2 · utility
2Cited by
8References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 10, 2012 |
| Grant date | Nov 13, 2018 |
| Priority date | — |
| Expiry date | Sep 10, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of treating neurological disorders in a subject, by activating a DISC1 pathway. Methods of promoting neurogenesis in adult neural progenitor cells, enhancing nerve generation and treating GSK3 disorders as well as related compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.